Saturday, 25 January 2025

Week 494 Review - A reasonable week as Jubilee Metals recovers a little.

It was quite a bad week for the majority of my portfolio, with more shares down than up. However, a decent rise in both JLP:Jubilee Metals and PBX:Probiotix Health offset the losses and the deficit between cost and value narrowed by £1,584 to £121,795. The deficit between injection amount and value reduced to £49,628, and portfolio value increased to £117,534, helped by a £2,000 pension transfer.

Worst performer was CWR:Ceres Power, which dropped 11% to go 33% down.

CAPD:Capital fell 7% and is now 31% down with little prospect of me being able to get rid of them without taking a big loss.

TRY:TR Property Investment hasn't been behaving like a magic formula share as it is quite volatile. It dropped 5% this week to go 7% down.

JLP:Jubilee Metals went up 5%, but as my 2nd largest holding was a major contributor to this week's gains. I revised my target sell prices in the SIPP to allow me to get rid of them more quickly, but I still need them to go up to 7.5p from 4.5p this week before I sell any.

ASHM:Ashmore Group went up 6% but my holding is still 42% down. Hopefully if China looks like improving this will help ASHM.

FDM:FDM Group went up 6% and are now just 15% down, although that's still pretty disappointing given I've only had them a few weeks.

GAW:Games Workshop climbed 7% despite going ex-dividend this week, and my holding is now 54% up so dividend yield is going to be getting better and better.

PBX:Probiotix Health gave a decent trading statement, and shares went up 8%, but that still leaves me 66% down on the IPO price.

Share of the week was FOUR:4imprint, which went up 12% after a trading statement saying profit would be above expectations. Really glad I finished buying these with my monthly investment a few months ago, as they are now 6% in profit and looking pretty good.

Here's the ISA and shares portfolio after week 26 of year 10.

Weekly Change
Cash £64.18 +£0
Portfolio cost £114,352.47 +£0
Portfolio sell value
(bid price-commission)
£48,782.13 (-57.3%) +£989.69
Potential profits £0 +£0
Yr 10 Dividends £109.18 +£0
Yr 10 Interest £0.82             +£0
Yr 10 Profit from sales £327.55 +£0
Yr 10 proj avg monthly profit £64.62 (0.9%) -£2.58
Total Dividends £12,417.13 +£0
Total Interest £7.62 +£0
Total Profit from sales £17,602.85 +£0
Average monthly cash profit £258.86 (3.6%) -£0.52
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance 35% +0%

Not much happened, but large numbers of JLP:Jubilee Metals shares meant a £989 increase in this account.


2025 remains up, but can it last? If JLP:Jubilee Metals and OPTI:Optibiotix sort themselves out then it may. I've been saying that for quite a long time though.



Just above the trend line, but much better than being below it.


The SIPP looks like this after week 478 overall and week 10 of year 10.




Weekly Change
Cash£59.73
-£56.44
Portfolio cost£124,853.36
+£2,368.94
Portfolio sell value
(bid price - commission)
£68,628.61(-45.0%)+£594.89
Potential profits£4,391.50
+£292.54
Yr 10 Dividends£292.94
+£0
Yr 10 Interest£1.25
+£0
Yr 10 Profit from sales£1,906.90
+£0
Yr 10 proj avg monthly profit£935.71(13.7%)-£103.97
Total Dividends£16,409.59
+£0
Total Interest£14.15
+£0
Total Profit from sales£18,914.84
+£0
Average monthly cash profit£307.46(4.5%)-£0.65
(Sold stocks profit + Dividends
- Fees / Months)
Compound performance41%-1%

I had a tax rebate so injected £150 to go with it and bought another 6,682 shares in JLP:Jubilee Metals at 4.714p costing £319.99. The share price had a wobble just after so I could have got them cheaper if I had waited.

I also had my £2,000 pension transfer, so had another look at my magic formula spreadsheet. I tried ranking them without taking dividend into account, and that promoted ALPH:Alpha Group International near the top. They are a FTSE 250 company combining fintech and consultancy, and most of their investors are institutions. Their share price has taken an occasional nosedive, but they seem short term and there has been steady growth for the last 7 years. At a P/E ratio of 11.6 they are not ridiculously cheap, but not worryingly expensive either.

They are still 39th in the magic formula ranking if I include the dividend, but zoom up to 6th if dividend ranking is removed. They are ranked 11th on 5-year growth and 14th on ROI, with debt dropping them a bit as they are ranked 74th. For divi they are only ranked 306th as it's a bit stingy, but I'm hoping share price growth will make up for that, and they may pay a special divi if they have excess cash. I bought 40 shares at 2457p costing £999.66.

The other company I've been watching for a while is BPM:BP Marsh & Partners. They invest in early stage financial services businesses, so by specialising in an area they know lots about, I figure they have more chance of being successful. Their share price was growing fairly steadily for 5 years, but much quicker for the last 2, with a spike upwards at the end of 2024. They are down a bit off that spike now, but with a P/E ratio of 6 seem quite cheap. In my magic formula spreadsheet they rank 5 on debt, 31 on growth, 67 on ROI and 289 on dividend, resulting in an overall ranking of 33. I bought 149 shares at 696.2p costing £1,049.29.

Potential profits went up £292 thanks to rises in FOUR:4imprint, GAW:Games Workshop, AJB:AJ Bell, III:3i Group, JLP:Jubilee Metals and PAF:Pan African Resources, with some of the shine taken off by drops in IGG:IG Group, BHP:BHP Group and ALU:Alumasc Group. Portfolio value increased by less that the ISA due to fewer JLP:Jubilee Metals shares being held.


The injection line is trying to get away from the green line!


Not as far above the trend line as the ISA, but the line is a lot less steep.


There were quite a few candidates for my pension transfer money this week. I was considering doubling my holding in IHP:Integrafin and RIO:Rio Tinto but will probably use proceeds from selling JLP:Jubilee Metals to do that. I'm also watching BRK:Brooks Macdonald Group. They are an investment management company and rank number 24 on my magic formula, and are about to move to the main market from AIM. The problem is their share price has been nose-diving for the last five months and their P/E ratio is 37, so they are definitely not cheap even at this price. They intend moving to the main market in March, so I will watch them in the lead up to that and if there's a reversal of their decline, may get some. It's encouraging that in the past I would have waded straight in and bought them, but I've caught too many falling knives and suffered lengthy periods in the red to do that again.

No comments:

Post a Comment